Write a summary report for the clinical trials
Use the list of clinical trials and the example of reports are attached please include inclusion/exclusion criteria for each trial
Amgen Europe B.V., Eden Biologics, Inc., Taiwan EB1001
(proposed denosumab biosmilar) 3 https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-002187-49/HU
8/16/2021 ongoing SQ injection
Cellitron CT-P41
(proposed denosumab biosimilar) 3 https://clinicaltrials.gov/ct2/show/NCT04757376
06/17/2021 ongoing
est 3/2023 SQ injection
Teva Branded Pharmaceutical Products R&D, Inc. TVB-009P
(proposed denosumab biosimilar) 3 https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-005548-48/BG
09/06/21 ongoing SQ injection
Biocon Biologics UK Ltd Bmab 1000
(proposed denosumab biosimilar) 3 https://clinicaltrials.gov/ct2/show/NCT05345691?cond=Bmab+1000&draw=2&rank=1
05/24/2022 6/20/2024
ongoing SQ Injection
Grünenthal GmbH Neridronic acid 3 https://clinicaltrials.gov/ct2/show/NCT02972359?cond=Neridronic+acid&draw=2&rank=1
12/20/2016 1/9/2019 Intravenous
Fresenius Kabi SwissBioSim GmbH FKS518
(proposed denosumab biosimilar) 3 https://clinicaltrials.gov/ct2/show/NCT04934072
7/5/2021 7/26/2023 SQ Injection
Luye Pharma Group Ltd. LY06006
(proposed denosumab biosimilar) 3 https://clinicaltrials.gov/ct2/show/NCT05060406
06/30/2019 12/31/2021 SQ Injection
Shanghai Biomabs Pharmaceutical Co., Ltd. CMAB8807
(proposed denosumab biosimilar) 3 https://clinicaltrials.gov/ct2/show/NCT04591275
03/31/2021 07/01/2021 SQ Injection